263 related articles for article (PubMed ID: 37109674)
41. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
42. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
Front Genet; 2022; 13():978840. PubMed ID: 36186442
[TBL] [Abstract][Full Text] [Related]
43. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
44. Systematic analysis of expression profiles and prognostic significance for MMDS-related iron-sulfur proteins in renal clear cell carcinoma.
Yang L; Chen YX; Li YY; Liu XJ; Jiang YM; Mai J
Sci Rep; 2022 Nov; 12(1):19637. PubMed ID: 36385109
[TBL] [Abstract][Full Text] [Related]
45. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
[TBL] [Abstract][Full Text] [Related]
46. Identification of potential biomarkers for progression and prognosis of renal clear cell carcinoma by comprehensive bioinformatics analysis.
Dong H; He Z; Wang H; Ding M; Huang Y; Li H; Shi H; Mao L; Hu C; Wang J
Technol Health Care; 2024; 32(2):897-914. PubMed ID: 37483037
[TBL] [Abstract][Full Text] [Related]
47. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
[TBL] [Abstract][Full Text] [Related]
48. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
49. Low
Xie Z; Chen N
Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311
[TBL] [Abstract][Full Text] [Related]
50. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
[TBL] [Abstract][Full Text] [Related]
51. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
Liu S; Yu Y; Wang Y; Zhu B; Han B
Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
[TBL] [Abstract][Full Text] [Related]
52. A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.
Yang W; Chen H; Ma L; Dong J; Wei M; Xue X; Li Y; Jin Z; Xu W; Ji Z
Aging (Albany NY); 2022 Dec; 14(24):10107-10124. PubMed ID: 36585925
[TBL] [Abstract][Full Text] [Related]
53. Bioinformatics analysis of markers based on m
Liu L; Zhuang M; Tu XH; Li CC; Liu HH; Wang J
Cell Biol Int; 2023 Jan; 47(1):260-272. PubMed ID: 36200528
[TBL] [Abstract][Full Text] [Related]
54. Mining database and verification of PIK3CB as a marker predicting prognosis and immune infiltration in renal clear cell carcinoma.
Ye J; Zeng T
Medicine (Baltimore); 2022 Jun; 101(22):e29254. PubMed ID: 35665729
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
Zhao YW; Ma W; Jiang F; Xie Y; Tang L
Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
[TBL] [Abstract][Full Text] [Related]
56. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma.
Hong P; Huang W; Du H; Hu D; Cao Q; Wang Y; Zhang H; Tong S; Li Z; Tong M
Front Genet; 2022; 13():1009555. PubMed ID: 36406128
[No Abstract] [Full Text] [Related]
58. HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
Cui Y; Zhang C; Li Y; Ma S; Cao W; Guan F
Cell Biol Int; 2021 Jun; 45(6):1246-1259. PubMed ID: 33559901
[TBL] [Abstract][Full Text] [Related]
59. Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis.
Yu B; Zhang J; Sun Z; Cao P; Zheng X; Gao Z; Cao H; Zhang F; Wang W
Medicine (Baltimore); 2021 Jan; 100(1):e24257. PubMed ID: 33429832
[TBL] [Abstract][Full Text] [Related]
60. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
